HH
Insider selling
Howard Horn sold $108K of RARE stock
Howard Horn, Chief Financial Officer of Ultragenyx Pharmaceutical Inc. (RARE), sold 7,066 shares of RARE stock worth $108K, per an SEC Form 4 filed Oct 19, 2026.
It was an open-market sale.
The trade happened on Oct 15, 2026, 4 days before it was made public.
RARE has moved +5.6% since the trade date, from $15.17 to $16.02 (Oct 20, 2026 close).
- Traded
- Oct 15, 2026
- Disclosed
- Oct 19, 2026
- Filing delay
- 4 days
- Price since
- +5.6%
- Role
- Chief Financial Officer
- Source
- SEC Form 4
More RARE insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.